3 results  1 of 1 

1 Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion
Kenji Watanabe
Intest Res.2020;18(4):347-354.   Published online 2020 October 26     DOI: http://dx.doi.org/10.5217/ir.2020.00032
      
2 Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea
Jason Jungsik Song, Yeong Wook Song, Sang Cheol Bae, Hoon-Suk Cha, Jung-Yoon Choe, Sung Jae Choi, Hyun Ah Kim, Jinseok Kim, Sung-Soo Kim, Choong-Ki Lee, Jisoo Lee, Sang-Heon Lee, Shin-Seok Lee, Soo-Kon Lee, Sung Won Lee, Sung-Hwan Park, Won Park, Seung Cheol Shim, Chang-Hee Suh, Bin Yoo, Dae-Hyun Yoo, Wan-Hee Yoo
J Korean Med Sci.2018;33(52):e346.  Published online 2018 December 18     DOI: http://dx.doi.org/10.3346/jkms.2018.33.e346
      
3 Early Biologic Treatment in Pediatric Crohn's Disease: Catching the Therapeutic Window of Opportunity in Early Disease by Treat-to-Target
Ben Kang, Yon Ho Choe
Pediatr Gastroenterol Hepatol Nutr.2018;21(1):1-11.   Published online 2018 January 12     DOI: http://dx.doi.org/10.5223/pghn.2018.21.1.1
      

 1 of 1